The diagnostic utility of somatostatin receptor scintigraphy in oncology
- 1 September 1996
- journal article
- review article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 122 (9) , 513-532
- https://doi.org/10.1007/bf01213548
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Evaluation in vitro and in rats of161Tb-DTPA-octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- All Five Cloned Human Somatostatin Receptors (hSSTR1-5) Are Functionally Coupled to Adenylyl CyclaseBiochemical and Biophysical Research Communications, 1994
- Somatostatinrezeptor-Szintigraphie in der Primärdiagnostik und Nachsorge bei GastrinomenDeutsche Medizinische Wochenschrift (1946), 1994
- Long-Term Exposure to SMS 201-995 Inhibits Proliferation and Calcitonin Release in Neoplastic C-CellsHormone and Metabolic Research, 1993
- Localization of neuroendocrine tumours and insulinomas using radiolabeled somatostatin analogues, 123 I‐Try3‐octreotide and 111in‐pentatreitideClinical Endocrinology, 1993
- In vivo application of [111In-DTPA-D-Phe1]-octreotide for detection of somatostatin receptor-positive tumors in ratsLife Sciences, 1991
- [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validationLife Sciences, 1991
- New Radionuclide Tracers for the Diagnosis and Therapy of Medullary Thyroid CarcinomaClinical Nuclear Medicine, 1988
- New specific radioligand for one subpopulation of brain somatostatin receptorsLife Sciences, 1985
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982